0 items USD 0.00Search
Your search for "gbi research respiratory tract infections drug development pipeline review 2018" gave back 61491 results.
HAI is a term used to describe all infections that do not stem from the patient’s original diagnosis on admission. HAIs are caused by bacteria,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Hospital-Acquired Infection Control market size was valued at US$ 5578.1 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Bioconjugate Development Services market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by...
Catalog:
GIR
February 2024
Price: USD 3,480.00
The global Recurrent Urinary Tract Infection Treatment market size was valued at US$ million in 2022. With growing demand in downstream market, the...
Catalog:
LPI
December 2023
Price: USD 3,660.00
The global Bioconjugate Development Services market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Hospital-Acquired Infections Assays market size was valued at USD 4187.8 million in 2023 and is forecast to a readjusted size of USD 6676...
Catalog:
GIR
February 2024
Price: USD 3,480.00
The global Machine Learning in Respiratory Diseases market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million...
Catalog:
GIR
December 2023
Price: USD 3,480.00
The global AI in Respiratory Diseases market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with...
Catalog:
GIR
December 2023
Price: USD 3,480.00
Publisher' newest research report, the “Infection Surveillance Services Industry Forecast” looks at past sales and reviews total world Infection...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Infection Prevention Surveillance market size was valued at US$ million in 2022. With growing demand in downstream market, the Infection...
Catalog:
LPI
December 2023
Price: USD 3,660.00
The global AI in Respiratory Diseases market size was valued at US$ million in 2022. With growing demand in downstream market, the AI in Respiratory...
Catalog:
LPI
December 2023
Price: USD 3,660.00
Global pharmacovigilance and drug safety software market will reach $432.3 million by 2031, growing by 7.3% annually over 2021-2031, driven by the...
Catalog:
Grace Market Data
July 2022
Price: USD 3,480.00
The global Machine Learning in Respiratory Diseases market size was valued at US$ million in 2022. With growing demand in downstream market, the...
Catalog:
LPI
December 2023
Price: USD 3,660.00
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma,...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Hospital-Acquired Infections Assays market size was valued at US$ 3981.5 million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
January 2024
Price: USD 3,660.00
